In Case You Missed It

Russell continues high into midday; IESC, TBSI, and JRCC lead gainers

SMALLCAP MARKETPLACE
SCI Microbloggers | Dec 08, 2008 1:09pm EST
Rating: Unrated
Small-cap stocks remained solidly higher into mid-session activity, with industrial, commodity and energy stocks paving the way higher after President-elect Obama announced plans for a massive infrastructure project over the weekend. Some of today's small-cap gainers included Integrated Electrical Services Inc. (Nasdaq:IESC), TBS International Ltd. (Nasdaq:TBSI) and James River Coal Co. (Nasdaq:JRCC).

Other Market Watch highlights included:

• Commodities in general were in favor today, with crude oil prices climbing 7%, while energy stocks were up more than 4%.  
• On the downside, personal products firms, hypermarkets, food distributors, retail drug companies and restaurants were the primary losing sectors.  
• The best performers so far today have been industrial REITs, metal and mining stocks, automobile manufacturers, aluminum firms and steel companies.
• Small-cap stocks remained solidly higher into mid-session activity, with industrial, commodity and energy stocks paving the way higher.  
• A big part of the early rise in stocks was tied to news this weekend that Obama was planning a massive infrastructure stimulus project.  

Small Cap Gainers:

Integrated Electrical Services Inc. jumped 34% presumably riding the wave of industrial and energy-related services companies higher. See (Nasdaq:IESC).  
TBS International Ltd. jumped 30% as the ocean transportation services company got an earnings-related lift. See (Nasdaq:TBSI).  
James River Coal Co. rallied 26%, receiving a lift with other beaten-down commodity names. See (Nasdaq:JRCC).
Cemex rallies as Deutsche Bank says it may gain from U.S. plan. See (NYSE:CX).

Small Cap Losers:

• The Talbots announces CFO retires, hires a new COO. Shares fall over 12%. See (NYSE:TLB).  
Radian Group dips 10% on lower-than-average volume. See (NYSE:RDN).
Blyth cuts earnings outlook, down 4% in light after-hours trade. See (NYSE:BTH).  
Allos Therapeutics slumping 21% in pre-market, reports Propel trial results. See (Nasdaq:ALTH).

For access to the full article, you must be a registered member - it's FREE.

Already a member? Please log in below

IESC Fast Facts:

Advertise | Contact Us | About Us | Contributors | Become a Contributor | Jobs | Press Releases